Center-Authored Papers

Filters: Author is Drescher, Charles W  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
Virus Attachment
Urinary Tract Infections
Up-Regulation
United States
Tumor Suppressor Protein p53
Tumor Markers, Biological
Shah CA, Lowe KA, Paley P, Wallace E, Anderson GL, McIntosh MW, Andersen MR, Scholler N, Bergan LA, Thorpe JD et al..  2009.  Influence of ovarian cancer risk status on the diagnostic performance of the serum biomarkers mesothelin, HE4, and CA125.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 18(5):1365-72. Abstract
Lowe KA, Shah C, Wallace E, Anderson G, Paley P, McIntosh MW, Andersen MR, Scholler N, Bergan L, Thorpe J et al..  2008.  Effects of personal characteristics on serum CA125, mesothelin, and HE4 levels in healthy postmenopausal women at high-risk for ovarian cancer.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 17(9):2480-7. Abstract
Ventura AP, Radhakrishnan S, Green A, Rajaram SK, Allen AN, O'Briant K, Schummer M, Karlan B, Urban ND, Tewari M et al..  2010.  Activation of the MEK-S6 pathway in high-grade ovarian cancers.. Applied immunohistochemistry & molecular morphology : AIMM / official publication of the Society for Applied Immunohistochemistry. 18(6):499-508. Abstract
McIntosh MW, Anderson G, Drescher CW, Hanash SM, Urban ND, Brown P, Gambhir SS, Coukos G, Laird PW, Nelson B et al..  2008.  Ovarian cancer early detection claims are biased.. Clinical cancer research : an official journal of the American Association for Cancer Research. 14(22):7574;authorreply7577-9.
Transduction, Genetic
TRANSCRIPTION FACTORS
Time Factors
Tight Junctions
Tandem Mass Spectrometry
Survival Analysis
Surface Plasmon Resonance